Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 5/20 | 0.41 |
| ▸ | NTSR1 | P30989 | 5/20 | 0.40 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | CAPN1 | P07384 | 4/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.38 |
| ▸ | APLNR | P35414 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29567365 | 0.98 | NTSR1 (0.40) | OPRD1NTSR1NTSR2ELANECAPN1 | |
| SCHEMBL29567235 | 0.98 | NTSR1 (0.40) | OPRD1NTSR1NTSR2ELANECAPN1 | |
| SCHEMBL29568037 | 0.96 | CAPN1 (0.42) | OPRD1NTSR1NTSR2ELANECAPN1 | |
| SCHEMBL29567142 | 0.95 | ELANE (0.42) | NTSR1NTSR2ELANECAPN1CTSB | |
| SCHEMBL29692555 | 0.90 | NTSR2 (0.40) | NTSR1NTSR2ELANECAPN1CTSB | |
| SCHEMBL29411300 | 0.88 | ELANE (0.46) | ELANECALCRL | |
| SCHEMBL29567586 | 0.87 | XIAP (0.42) | OPRD1NTSR1ELANECAPN1CTSB | |
| Larazotide SCHEMBL23668121 | 0.86 | CAPN1 (0.43) | OPRD1NTSR1CAPN1 | |
| Larazotide SCHEMBL23668120 | 0.86 | CAPN1 (0.43) | OPRD1NTSR1CAPN1 | |
| Larazotide SCHEMBL28795844 | 0.86 | CAPN1 (0.43) | OPRD1NTSR1CAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220280615-A1 | IMMUNE TOLERANT ELASTIN-LIKE RECOMBINANT PEPTIDES AND METHODS OF USE | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2022-09-08 | — | — | US | claimed |
| CN-114667160-A | Immune tolerant elastin-like recombinant peptides and methods of use thereof | 犹他大学研究基金会 | 2022-06-24 | — | — | CN | claimed |
| US-12162923-B2 | Immune tolerant elastin-like peptide tetramer guided nanoparticles and methods of use | UNIVERISTY OF UTAH RESEARCH FOUNDATION (US) | 2024-12-10 | — | — | US | disclosed |
| US-11957762-B2 | Immune tolerant and non-immune tolerant elastin-like recombinant peptides and methods of use | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2024-04-16 | — | — | US | disclosed |
| US-20220280615-A1 | IMMUNE TOLERANT ELASTIN-LIKE RECOMBINANT PEPTIDES AND METHODS OF USE | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2022-09-08 | — | — | US | disclosed |
| EP-4017541-A1 | IMMUNE TOLERANT ELASTIN-LIKE RECOMBINANT PEPTIDES AND METHODS OF USE | University of Utah Research Foundation (US) | 2022-06-29 | — | — | EP | disclosed |
| CN-114667160-A | Immune tolerant elastin-like recombinant peptides and methods of use thereof | 犹他大学研究基金会 | 2022-06-24 | — | — | CN | disclosed |
| US-20220112268-A1 | Immune Tolerant Elastin-Like Peptide Tetramer Guided Nanoparticles And Methods Of Use | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2022-04-14 | — | — | US | disclosed |